VANCOUVER, BC and NEW YORK, NY - (NewMediaWire) - October 13, 2015 - Pivot Pharmaceuticals Inc. (OTCQB: PVOTF) ("Pivot" or the "Company"), an emerging biotechnology company engaged in the development of therapeutics to meet unmet medical needs in women's health, is pleased to announce today they have engaged leading investor relations firm PCG Advisory Group (PCG) as their agency of record for capital markets advisory services, strategic and tactical digital and social media communications and public relations advisory services.
Pivot's Chairman, Dr. Ahmad Doroudian, said, "We determined that Jeff Ramson and his team at PCG would be the best fit for us. PCG's senior team has strong contacts across key U.S. Capital Markets and extensive experience building out digital and social media for their clients. As we strive to become a leader in women's health, we welcome the team's counsel."
Jeff Ramson, founder and CEO of PCG, added, "Pivot Pharmaceuticals has a unique focus on improving women's health by repositioning existing drugs. The team at PCG looks forward to partnering with Pivot Pharmaceuticals, introducing the Company to our many contacts and refining the Company's messages for investors and the media. We look forward to a long and successful partnership."
About Pivot Pharmaceuticals Inc.
Pivot is an early stage biopharmaceutical company engaged in the development and commercialization of therapeutic pharmaceutical products, with a strategic emphasis on the innovation of new therapeutic uses for existing drugs to treat unmet conditions related to women's health. Pivot has identified ideal candidates for the treatment of Dysmenorrhea, lower urinary tract symptoms (LUTS), and menopausal symptoms (hot flushes)
About PCG Advisory
Founded in 2008, PCG Advisory Group is dedicated to the delivery of top tier capital markets advisory services, strategic and tactical digital and social media communications and cutting edge media and public relations for public and privately held companies. The team at PCG has extensive experience with life sciences and healthcare, high technology, metals and mining, financial services and emerging growth companies from around the globe.
PCG's Capital Markets Advisory Services include overall investor strategy development to increase and leverage investor awareness, visibility and credibility.
PCG's Social and Digital Media services include leveraging social and professional digital media sites to effectively and accurately communicate client stories. As an aggregation, distribution, and engagement platform, PCG reaches thousands of individual, retail and institutional investors using proprietary techniques, search engine optimization, online marketing, website development and our proprietary and extensive distribution network. PCG's Media and Public Relations services are a strategic and integral component of all Corporate Communications. The media and public relations team works with print, broadcast, online news sites and bloggers to communicate the best client story at the right time. PCG also has the capabilities to assist a company during a merger, acquisition or crisis.
Communicating the client's story accurately and effectively is tantamount to maximizing exposure to its current and potential stakeholders.
Except for historical information contained herein, the matters set forth above may be forward-looking statements that involve certain risks and uncertainties that could cause actual results to differ from those in the forward-looking statements. Words such as anticipate, believe, estimate, expect, intend, and similar expressions, as they relate to Pivot Pharmaceuticals or its management, identify forward-looking statements. Such forward-looking statements are based on the current beliefs of management, as well as assumptions made by and information currently available to management. Actual results could differ materially from those contemplated by the forward-looking statements as a result of certain factors, such as the level of business and consumer spending, the amount of sales of Pivot's products, the competitive environment within the industry, the ability of Pivot to continue to expand its operations, the level of costs incurred in connection with Pivot's expansion efforts, economic conditions in the industry, and the financial strength of Pivot's customers and suppliers. Pivot does not undertake any obligation to update such forward-looking statements. Investors are also directed to consider all other risks and uncertainties.